All
  • All
  • Insight
  • Research Services
  • Preclinical CRO
  • Animal Resource Bank
CN
中文 English
Latest News

Latest News

Focusing on cutting-edge technologies and research advancements,
sharing Aniphe BioLab’s achievements in scientific innovation, Professional insights
and practical experience in the fields of laboratory animals and preclinical research.

Literature Review | Has the Secret to Slowing Aging Been Discovered? The Gut Microbiota May Hold the Key!

Introduction

Since ancient times, the quest for immortality has captivated humanity; whether in historical records or in film and television, we find countless accounts of efforts to discover the elixir of life. As human civilization has advanced, we have come to recognize that eternal life is but a fantasy. Yet slowing down the aging process may indeed be within our reach.

On August 9, 2021, researchers at the APC Microbiome Ireland Research Centre of University College Cork published in… Nature Aging》 A research paper titled “Microbiota from young mice counteracts selective age-associated behavioral deficits” was published.

 

The study indicates that, Transplanting the gut microbiota from young mice into aged mice can, to a certain extent, counteract age‑related cognitive impairments in the brains of the older animals. These findings suggest that fecal microbiota transplantation… (FMT) It may hold therapeutic potential for age-related cognitive decline.

--------------------------------------

This Issue’s Interpretive Article

The gut microbiota is an important regulator of host immunity and brain health, and it has increasingly come to the fore in recent years. During aging, the microbial composition within the body undergoes substantial changes, which are associated with poorer health outcomes and greater frailty in older adults. However, despite these observations, robust evidence remains lacking to establish mechanistic links between the gut microbiota and brain health or neuroimmune function during the aging process.

Aging induces alterations in metabolism and immune function, which in turn disrupt brain function and behavior, including impairments in hippocampus‑dependent cognitive processes. However, it remains entirely unknown whether the microbiota from young mammalian hosts can reverse the various age‑related dysfunctions observed in aged organisms.

To determine whether fecal microbiota transplantation (FMT) from young mice can ameliorate age‑related neurocognitive and immune impairments, researchers collected the fecal microbiota of juvenile mice and transplanted it into aged mice, which were then divided into three major groups.

 

The fecal microbiota from the first group of young mice (3–4 months old) was transplanted into aged mice (“aged yFMT,” 19–20 months old).

The second group of aged mice received treatment with the fecal microbiota from naïve aged mice during FMT administration (“aged oFMT,” 19–20 months).

In the third group, young mice received the same yFMT mixture (“young yFMT”).

The detailed schedule is shown in the figure:

Figure 1: Study Grouping and Experimental Procedure

 

The research team found that, following the transplantation of microbiota from young mice, the gut microbiota of aged mice became “younger,” with enhanced immune function in each individual, increased brain vitality, a reshaping of hippocampal metabolomics, and improvements in behavioral cognition.

To investigate the impact of aging on the fecal microbiota, researchers employed 16S rRNA amplicon sequencing to analyze the baseline fecal microbiota of young and aged mice, and reassessed the composition and diversity of the FMT group after 4 weeks to examine FMT engraftment and colonization dynamics (Figure 1).

Notably, the researchers found no difference between groups in the number of taxa gained or lost (Figure 6). Prior to FMT, young and old mice exhibited distinct differences in β-diversity. However, following FMT, these differences in β-diversity were no longer statistically significant (Figure 2).

Figure 2

 

Based on analyses using the Simpson and Shannon indices, neither temporal nor inter-group variations in α-diversity were significant. Among all taxonomic groups, only the Chao1‑estimated richness showed a significant decline following FMT (Figure 3).

Figure 3

This indicates that the reduced taxa following FMT maintained a uniform distribution. Twenty genera exhibited significant changes after FMT (Figure 4).

Figure 4

Experiments have demonstrated that the microbiota of young individuals may exert beneficial effects on the aging process in older adults, ameliorating age-related phenotypes and slowing the progression of aging.

Figure 5

Researchers also employed the Y-maze and novel object recognition (NOR) tests to assess short-term working memory and short-term recognition memory. The final experimental data indicate that yFMT can ameliorate specific aspects of behavioral deficits associated with aging.

Figure 6

 

Researchers state that future studies should further elucidate how specific gut microbes drive these changes and identify the direct mechanistic basis underlying the rejuvenation of the aging brain. Although yFMT did not reverse specific age‑related deficits in behavior, immunity, or neurogenesis, this study provides foundational evidence suggesting that the gut microbiota should be regarded as a potential therapeutic target for addressing hippocampus‑dependent aspects of age‑related functional decline.

 

 

References:

https://www.nature.com/articles/s43587-021-00093-9

 

 

 

Organized by | Aniphe BioLab Marketing Department

Supervisor  | Always

Editor-in-chief  | Lemon

Submission | Solar wind

Editor-in-chief  | Little Swallow

Editor  |  Lemon

PREVIOUS:

Disease Model | Emphasizing Chronic Mountain Sickness! Hypoxic Pulmonary Hypertension (HPH) Poses Numerous Risks

NEXT:

Mouse Classroom | Introduction to the Genotypes of Transgenic Mice and ApoE Knockout Mice